However, its precise role in DOR and the therapeutic potential targeting pyroptosis pathways remain underexplored
Our experienced team will guide you through the process, from initial consultation to ongoing monitoring, ensuring that the treatment aligns with your health goals and medical history
The renal or extrarenal expression of 1--hydroxylase (CYP27B1) enzymatic action converts 25(OH)VD 3 to an active metabolite 1,25-dihydroxy vitamin D 3 (1,25(OH) 2 VD 3) 13
They stimulate insulin release
Real-world observational studies examining clinical data have not identified consistent patterns of increased rates of general vision problems associated with GLP-1 use, though most studies were not specifically designed to detect rare ocular events
A 2022 analysis in Pharmacotherapy found that pharmacist-led medication review at GLP-1 initiation identified a clinically significant interaction concern in 14% of patients, the most common being an oral contraceptive or levothyroxine combination [13]